The function of the cell culture core will be to provide strictly defined cells in culture for the participatinginvestigators. The cell culture core will be responsible for the the isolation of primary cultures of humandermal microvascular endothelial cells, murine blood outgrowth endothelial cells (BOEC), murine smoothmuscle cells, murine pulmonary vein and artery endothelial cells and murine fibroblasts. Cell lines includingmurine liver cells and human pulmonary vein and artery endothelial cells, will also be cultured. Primary cellswill be grown in endotoxin-free conditions utilizing experienced cell culture techniques. The.purity of the cellswill be verified using a variety of immunological techniques and functional assays. The cell culture core willdistribute plates of cells to all investigators for the studies outlined in their proposals.The laboratory hasrigorous techniques to provide endotoxin-free cell cultures to minimize cell activation, a critical criteria formany studies. This is accomplished by using endotoxin-free media and regular testing of all reagents usedfor cell culture for endotoxin using the limulus amoebocyte lysate assay. The P.I. and technician have manyyears of experience growing endothelial and other cells in culture. Sickle cell anemia is a devastating disease manifest by anemia, painful crises and organ injury such asstroke. The cells cultured in this Core will be used by investigators to test new treatments. By using cells,safety and effectiveness can be studied before giving new therapies to humans.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL055552-11A1
Application #
7226095
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-12-01
Project End
2011-11-30
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
11
Fiscal Year
2007
Total Cost
$129,196
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Solovey, Anna; Somani, Arif; Belcher, John D et al. (2017) A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade. Am J Hematol 92:1119-1130
Belcher, John D; Chen, Chunsheng; Nguyen, Julia et al. (2014) Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123:377-90
Shirodkar, Apurva V; St Bernard, Rosanne; Gavryushova, Anna et al. (2013) A mechanistic role for DNA methylation in endothelial cell (EC)-enriched gene expression: relationship with DNA replication timing. Blood 121:3531-40
Schaer, Dominik J; Buehler, Paul W; Alayash, Abdu I et al. (2013) Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 121:1276-84
Nath, Karl A; Grande, Joseph P; Farrugia, Gianrico et al. (2013) Age sensitizes the kidney to heme protein-induced acute kidney injury. Am J Physiol Renal Physiol 304:F317-25
Mulrooney, Daniel A; Ness, Kirsten K; Huang, Sujuan et al. (2013) Pilot study of vascular health in survivors of osteosarcoma. Pediatr Blood Cancer 60:1703-8
Weber, M L; Chen, C; Li, Y et al. (2013) Morphine stimulates platelet-derived growth factor receptor-? signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo. Br J Anaesth 111:1004-12
Martin-Ramirez, Javier; Hofman, Menno; van den Biggelaar, Maartje et al. (2012) Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc 7:1709-15
Nath, Karl A (2012) Human AKI and heme oxygenase-1. J Am Soc Nephrol 23:971-4
Juskewitch, Justin E; Knudsen, Bruce E; Platt, Jeffrey L et al. (2012) LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol 180:32-40

Showing the most recent 10 out of 107 publications